Literature DB >> 16081911

Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.

Joanne Peter1, Derek Armstrong, Caron A Lyman, Thomas J Walsh.   

Abstract

We investigated the utility of mechanism-based fluorescent probes for determination of MICs (FMICs) of amphotericin B and caspofungin against Candida spp. and Aspergillus spp. Amphotericin B was selected as a membrane-active antifungal agent, and caspofungin was selected as a cell wall-active agent. FMICs were also compared to the MIC determined by CLSI (formerly NCCLS) methods. Five isolates per species of Candida albicans, Candida glabrata, Candida parapsilosis, Aspergillus fumigatus, and Aspergillus terreus were studied with either amphotericin B or caspofungin. The fluorescent probes, carboxyfluorescein diacetate (CFDA) for cytoplasmic esterase activity and dihexyloxacarbocyanine iodide (DiOC6) for cell membrane potential, were each added to their respective plates. MICs and FMICs were determined in at least three separate experiments (in duplicate). Fluorescence was measured using a 96-well plate fluorometer. For amphotericin B and caspofungin, the FMIC end point was the lowest concentration of drug at which the percent growth inhibition from treated organisms versus control organisms displayed 80% inhibition for amphotericin B and 50% inhibition for caspofungin as measured by a fluorescent signal. The MIC for amphotericin B was defined as the lowest concentration of antifungal displaying no visible growth for both Aspergillus and Candida spp. The MIC for caspofungin was the lowest concentration of drug that displayed a minimum effective concentration for Aspergillus spp. For Candida spp., the MIC for caspofungin was defined as the concentration at which the antifungal agent significantly inhibits the organism. The FMICs of both antifungals, as measured by the DiOC6 membrane probe, showed good agreement (83% to 100%), within one well dilution, with the MICs against amphotericin B and caspofungin for all species. Also, the FMICs measured by the CFDA cytoplasmic esterase probe reflecting damage due to cell wall or cell membrane showed strong agreement (79 to 100%) with the MICs of both amphotericin B and caspofungin for all species. There was no significant difference in comparisons of MIC and FMIC values (P > or = 0.05). The use of fluorescent probes provides a mechanism-based method of determination of MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp. that correlates well with standard methods.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081911      PMCID: PMC1233965          DOI: 10.1128/JCM.43.8.3788-3792.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

Review 1.  Antifungal susceptibility testing. New technology and clinical applications.

Authors:  M A Pfaller; W L Yu
Journal:  Infect Dis Clin North Am       Date:  2001-12       Impact factor: 5.982

Review 2.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Mitochondrial membrane potential and ageing in Podospora anserina.

Authors:  F Koll; C Sidoti; V Rincheval; G Lecellier
Journal:  Mech Ageing Dev       Date:  2001-02       Impact factor: 5.432

Review 4.  Utility of mould susceptibility testing.

Authors:  Ana Espinel-Ingroff
Journal:  Curr Opin Infect Dis       Date:  2003-12       Impact factor: 4.915

5.  Dimethyl sulfoxide exposure facilitates phospholipid biosynthesis and cellular membrane proliferation in yeast cells.

Authors:  Yoshinori Murata; Takahito Watanabe; Masanori Sato; Yuko Momose; Toro Nakahara; Shu-ichi Oka; Hitoshi Iwahashi
Journal:  J Biol Chem       Date:  2003-05-27       Impact factor: 5.157

6.  Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells.

Authors:  F A Gesek; P A Friedman
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

7.  Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.

Authors:  Frank C Odds; Mary Motyl; Roberto Andrade; Jacques Bille; Emilia Cantón; Manuel Cuenca-Estrella; Amanda Davidson; Christian Durussel; David Ellis; Elyse Foraker; Annette W Fothergill; Mahmoud A Ghannoum; Robert A Giacobbe; Miguel Gobernado; Rosemary Handke; Michel Laverdière; Wendy Lee-Yang; William G Merz; Luis Ostrosky-Zeichner; Javier Pemán; Sophia Perea; John R Perfect; Michael A Pfaller; Laurie Proia; John H Rex; Michael G Rinaldi; Juan-Luis Rodriguez-Tudela; Wiley A Schell; Christine Shields; Deanna A Sutton; Paul E Verweij; David W Warnock
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole.

Authors:  M A Pfaller; A Espinel-Ingroff; R N Jones
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Novel fluorescent broth microdilution method for fluconazole susceptibility testing of Candida albicans.

Authors:  R S Liao; R P Rennie; J A Talbot
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

10.  Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus.

Authors:  C C Chiou; N Mavrogiorgos; E Tillem; R Hector; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

View more
  1 in total

1.  Fluorescent Tracking of Yeast Division Clarifies the Essential Role of Spleen Tyrosine Kinase in the Intracellular Control of Candida glabrata in Macrophages.

Authors:  Zeina Dagher; Shuying Xu; Paige E Negoro; Nida S Khan; Michael B Feldman; Jennifer L Reedy; Jenny M Tam; David B Sykes; Michael K Mansour
Journal:  Front Immunol       Date:  2018-05-16       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.